This week, Social Market Analytics (SMA) looks at Furiex Pharmaceuticals, Inc. (NASDAQ: FURX ), a drug development company, engaged in the compound partnering business primarily in the United States. The company collaborates with pharmaceutical and biotechnology companies, worldwide, to enhance the value of their drug candidates by applying Furiex